Vol 71, No 2 (2020)
Clinical vignette
Published online: 2020-01-07

open access

Page views 2870
Article views/downloads 2414
Get Citation

Connect on Social Media

Connect on Social Media

Juvenile breast hypertrophy

Benedita Bianchi de Aguiar1, Rita Santos Silva2, Carla Costa2, Cintia Castro-Correia2, Manuel Fontoura2
Pubmed: 31909454
Endokrynol Pol 2020;71(2):202-203.

Abstract

Not required for Clinical Vignette.

Article available in PDF format

View PDF Download PDF file

References

  1. Akmal H, Marzida AL, Normala B. Juvenil Breast Hypertrophy: A successful breast reduction of 14.9% body weight without recurrence in a 5-year follow-up. Case Rep Surg. 2017; 2017(3491012).
  2. Karagüzel G, Bilen S, Karaçal N, et al. Virginal Breast Hypertrophy: Different Presentations of 2 Cases and the Role of Tamoxifen as an Adjuvant Therapy. J Pediatr Adolesc Gynecol. 2016; 29(5): e71–e74.
  3. Hoppe I, Patel P, Singer-Granick C, et al. Virginal Mammary Hypertrophy: A Meta-Analysis and Treatment Algorithm. Plast Reconstr Surg. 2011; 127(6): 2224–2231.
  4. Wolfswinkel EM, Lemaine V, Weathers WM. Hyperplastic Breast Anomalies in the Female Adolescent Breast. Semin Plast Surg. 2013; 27(1): 49–55.
  5. Baker SB, Burkey BA, Thornton P, et al. Juvenile gigantomastia: presentation of four cases and review of the literature. Ann Plast Surg. 2001; 46(5): 517–25; discussion 525.